EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss

Fangxiang Mu, Huyan Huo, Mei Wang, Ling Liu, Fang Wang

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2024.104322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Fangxiang Mu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Abortion, Habitual, Live Birth, Birth Rate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lanzhou University Second Hospital, Lanzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This real-world study aimed to assess the clinical efficacy and safety of intravenous immunoglobulin (IVIG) in treating unexplained recurrent pregnancy loss (uRPL) patients. A total of 238 patients with uRPL were enrolled in this retrospective study. According to the treatment, patients were assigned into treatment group (n=184, receiving IVIG+low molecular weight heparin [LMWH]) and control group (n=54, only LMWH). The primary outcome was the live birth rates (LBR) after 24 weeks of gestation. In addition, we performed subgroup analyses to assess the LBR in uRPL patients with age (≥30 years or

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulins, IntravenousAbortion, HabitualLive BirthBirth RateHumansFemalePregnancyAdultRetrospective StudiesHeparin, Low-Molecular-WeightTreatment Outcome

Stichwörter der Autor:innen

EfficacyIntravenous immunoglobulinReal-world studySafetyUnexplained recurrent pregnancy loss

Substanzen

Immunoglobulins, IntravenousHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China.
  • Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China. Electronic address: ery_fwang@lzu.edu.cn.

Förderung

  • Lanzhou University Second Hospital
  • Lanzhou University

Zitieren

APA

Mu, F., Huo, H., Wang, M., Liu, L., & Wang, F. (2024). Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104322

Vancouver

Mu F, Huo H, Wang M, Liu L, Wang F. Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104322

BibTeX
@article{Mu2024,
  author = {Mu, Fangxiang and Huo, Huyan and Wang, Mei and Liu, Ling and Wang, Fang},
  title = {Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2024.104322}
}
Kostenlos starten →